Ulthera Files For IPO

Mesa, Arizona-based Ulthera, the developer of medical devices aimed at the aesthetic medicine market, has filed for an IPO, saying that it is looking to raise up to $86.25M on the NASDAQ Global Market as ULTH. The IPO is being underwritten by J.P. Morgan, Citigroup, William Blair, and Canaccord Genuity. Ulthera is venture backed by Apposite Healthcare Fund and New Enterprise Associates.